RESUMEN
Patients with severe acute and chronic lower extremity wounds often present a significant challenge in terms of limb salvage. In addition to control of infection, assuring adequate perfusion and providing standard wound care, advanced modalities are often required to facilitate final wound closure. We herein present a case study on a diabetic patient with gangrene and necrotising soft-tissue infection who underwent a forefoot pedal amputation to control the sepsis. Despite his non invasive vascular studies demonstrating poor healing potential at this level, he was not deemed suitable for revascularisation by our vascular surgeons and ankle-level amputation was recommended. Nonetheless, over a 5-month period using multiple advanced wound care therapies, wound closure was ultimately achieved.
Asunto(s)
Pie Diabético/terapia , Recuperación del Miembro/métodos , Infecciones de los Tejidos Blandos/terapia , Técnicas de Cierre de Heridas , Apósitos Biológicos , Materiales Biocompatibles Revestidos , Pie Diabético/complicaciones , Pie Diabético/patología , Gangrena , Humanos , Masculino , Persona de Mediana Edad , Infecciones de los Tejidos Blandos/complicaciones , Infecciones de los Tejidos Blandos/patología , Cicatrización de HeridasRESUMEN
OBJECTIVE: To estimate the 2009 prevalence of diagnosed diabetes in Puerto Rico among adults ≥ 20 years of age in order to gain a better understanding of its geographic distribution so that policymakers can more efficiently target prevention and control programs. METHODS: A Bayesian multilevel model was fitted to the combined 2008-2010 Behavioral Risk Factor Surveillance System and 2009 United States Census data to estimate diabetes prevalence for each of the 78 municipios (counties) in Puerto Rico. RESULTS: The mean unadjusted estimate for all counties was 14.3% (range by county, 9.9%-18.0%). The average width of the confidence intervals was 6.2%. Adjusted and unadjusted estimates differed little. CONCLUSIONS: These 78 county estimates are higher on average and showed less variability (i.e., had a smaller range) than the previously published estimates of the 2008 diabetes prevalence for all United States counties (mean, 9.9%; range, 3.0%-18.2%).
Asunto(s)
Diabetes Mellitus/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Puerto Rico/epidemiología , Análisis de Área Pequeña , Adulto JovenRESUMEN
Advanced multimodal therapies are being used with increasing frequency in the management of difficult or complex wounds. Although the primary goal remains to expedite complete healing, secondary goals include avoidance of superimposed infection, repeated hospitalisations and subsequent amputations. We describe a case involving a limb- and life-threatening necrotising infection in a diabetic patient in which we successfully applied negative pressure wound therapy, dermal replacement therapy and pulsed radio frequency energy to achieve definitive healing. Further study is warranted to elucidate the most effective combinations of such therapies to promote healing of similarly complex wounds.
Asunto(s)
Ablación por Catéter/métodos , Dermis/trasplante , Pie Diabético/terapia , Terapia de Presión Negativa para Heridas/métodos , Cicatrización de Heridas , Desbridamiento/métodos , Pie Diabético/patología , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Chronic lower extremity wounds are a major source of morbidity and health care expenditure across the world. In the last decade, numerous advanced modalities have become available that can help expedite wound healing when standard wound care modalities are unsuccessful. In this case report, the authors present their early experience with one such modality that uses pulsed radiofrequency energy to initiate cell proliferation induction in chronic lower extremity wounds of different etiologies that had failed to respond to standard therapy.
Asunto(s)
Proliferación Celular/efectos de la radiación , Úlcera de la Pierna/radioterapia , Terapia por Radiofrecuencia , Cuidados de la Piel/instrumentación , Cuidados de la Piel/métodos , Cicatrización de Heridas/efectos de la radiación , Anciano , Enfermedad Crónica , Humanos , Masculino , Persona de Mediana Edad , Inducción de Remisión/métodosRESUMEN
UNLABELLED: The following case is an interesting presentation of gout and its long-term affects in a diabetic individual. The patient initially presented with ankle pain and, after radiographic examination, a suspicious lytic lesion in the talus and a fracture of the medial malleolus were identified. A full workup with bone biopsy was undertaken and, although the patient did not present in the typical fashion, gout was ultimately diagnosed. Based on our experience with this patient, we recommend that gout be included in the list of differential diagnoses in diabetic patients with ankle pain and radiographic evidence of articular and bone destruction. The diagnosis and treatment of gout are addressed in this paper as well. LEVEL OF CLINICAL EVIDENCE: 4.
Asunto(s)
Complicaciones de la Diabetes/diagnóstico , Gota/diagnóstico , Astrágalo , Complicaciones de la Diabetes/terapia , Gota/terapia , Humanos , Masculino , Persona de Mediana EdadRESUMEN
OBJECTIVE: We examined factors associated with screening for albuminuria and initiation of ACE inhibitor or angiotensin receptor blocker (ARB) treatment in diabetic patients. RESEARCH DESIGN AND METHODS: We conducted surveys and medical record reviews for 5,378 patients participating in a study of diabetes care in managed care at baseline (2000-2001) and follow-up (2002-2003). Factors associated with testing for albuminuria were examined in cross-sectional analysis at baseline. Factors associated with initiating ACE inhibitor/ARB therapy were determined prospectively. RESULTS: At baseline, 52% of patients not receiving ACE inhibitor/ARB therapy and without known diabetic kidney disease (DKD) were screened for albuminuria. Patients > or =65 years of age, those with higher HbA(1c), those with cardiovascular disease (CVD), and those without hyperlipidemia were less likely to be screened. Of the patients with positive screening tests, 47% began ACE inhibitor/ARB therapy. Initiation of therapy was associated with positive screening test results, BMI > or =25 kg/m(2), treatment with insulin or oral antidiabetic agents, peripheral neuropathy, systolic blood pressure > or =140 mmHg, and CVD. Of the patients receiving ACE inhibitor/ARB therapy or with known DKD, 63% were tested for albuminuria. CONCLUSIONS: Screening for albuminuria was inadequate, especially in older patients or those with competing medical concerns. The value of screening could be increased if more patients with positive screening tests initiated ACE inhibitor/ARB therapy. The efficiency of screening could be improved by limiting screening to diabetic patients not receiving ACE inhibitor/ARB therapy and without known DKD.
Asunto(s)
Nefropatías Diabéticas/diagnóstico , Nefropatías Diabéticas/tratamiento farmacológico , Tamizaje Masivo , Albuminuria/sangre , Albuminuria/complicaciones , Albuminuria/tratamiento farmacológico , Antagonistas de Receptores de Angiotensina , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Estudios Transversales , Nefropatías Diabéticas/complicaciones , Nefropatías Diabéticas/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de RiesgoRESUMEN
A diabetes epidemic emerged during the 20th century and continues unchecked into the 21st century. It has already taken an extraordinary toll on the U.S. population through its acute and chronic complications, disability, and premature death. Trend data suggest that the burden will continue to increase. Efforts to pre- vent or delay the complications of diabetes or, better yet, to prevent or delay the development of diabetes itself are urgently needed.
Asunto(s)
Complicaciones de la Diabetes , Diabetes Mellitus/epidemiología , Brotes de Enfermedades , Diabetes Mellitus/clasificación , Predicción , Humanos , Prevalencia , Factores de Riesgo , Estados UnidosRESUMEN
The focus of this paper is on the development of textile-based wearable electronics that can be integrated into military protective clothing. A materials and manufacturing survey was conducted to determine the best performing and most durable materials to withstand the rigors of textile manufacturing and potential military use. Narrow woven technology was selected as one of the most promising textile manufacturing methods. A working wearable narrow fabric version of the Universal Serial Bus (USB), as well as a radiating conductor, were successfully developed and fabricated. A circular knit T-shirt with an integrated spiral bus was also developed. Military products developed include components of a personal area network providing data and power transport, and a body-borne antenna integrated into a load-bearing vest.
Asunto(s)
Redes de Comunicación de Computadores/instrumentación , Medicina Militar/instrumentación , Monitoreo Ambulatorio/instrumentación , Ropa de Protección , Telecomunicaciones/instrumentación , Textiles , Diseño de Equipo , Análisis de Falla de Equipo , Estudios de Factibilidad , Ensayo de Materiales , Medicina Militar/métodos , Monitoreo Ambulatorio/métodos , Evaluación de la Tecnología Biomédica , Estados UnidosRESUMEN
OBJECTIVE: To estimate the prevalence of physical limitations associated with diabetes among U.S. adults > or =18 years of age. RESEARCH DESIGN AND METHODS: We conducted a cross-sectional analysis of the association between diabetes status and physical limitations using the 1997-1999 National Health Interview Survey (NHIS). Physical limitation was defined from self-reported degree of difficulty with nine tasks. RESULTS: People with diabetes had a higher proportion of any physical limitation than did people without diabetes overall (66 vs. 29%, P < 0.001), for both men (59 vs. 24%, P < 0.001) and women (72 vs. 34%, P < 0.001). Compared with those without diabetes, a higher proportion of people with diabetes had some physical limitation among all age groups, and the difference declined (all P < 0.001) with increasing age (46 vs. 18% for 18-44 years, 63 vs. 35% for 45-64 years, 74 vs. 53% for 65-74 years, and 85 vs. 70% for those 75 years and older). After controlling for demographic characteristics and several other confounders, the odds ratio of physical limitation among adults with diabetes versus those without diabetes was 1.9 (95% CI: 1.8-2.1). CONCLUSIONS: People with diabetes are much more likely to have a physical limitation than those without diabetes. Interventions are needed in this population to reduce progression from impairment to physical limitation and from physical limitation to disability, especially because the prevalence of diabetes is projected to increase dramatically in the next several decades.
Asunto(s)
Actividades Cotidianas , Diabetes Mellitus/epidemiología , Diabetes Mellitus/fisiopatología , Evaluación de la Discapacidad , Adolescente , Adulto , Distribución por Edad , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Análisis de Regresión , Estados Unidos/epidemiologíaRESUMEN
Linezolid, a mild monoamine oxidase inhibitor, is a commonly used antibiotic drug for the treatment of complicated skin and skin structure infections, including diabetic foot infections. Use of linezolid has been associated with serotonin syndrome, a potentially life-threatening condition typically caused by the combination of two or more medications with serotonergic properties, due to increased serotonin release. The goals of this article are to highlight the risk factors associated with the development of serotonin syndrome related to the use of linezolid and to aid in its prevention and early diagnosis. In this case series we report on two hospitalized patients who, while being treated with linezolid for pedal infections, developed serotonin syndrome. Both individuals were also undergoing treatment with at least one serotonergic agent for depression and had received this medication within 2 weeks of starting the antibiotic drug therapy. In these individuals, we noted agitation, confusion, tremors, and tachycardia within a few days of initiation of linezolid therapy. Owing to the risk of serotonin toxicity, care should be taken when prescribing linezolid in conjunction with any other serotonergic agent. Although serotonin syndrome is an infrequent complication, it can be potentially life threatening. Therefore, risks and benefits of therapy should be weighed before use.
Asunto(s)
Linezolid/efectos adversos , Síndrome de la Serotonina/inducido químicamente , Anciano , Pie Diabético/complicaciones , Humanos , Linezolid/uso terapéutico , Masculino , Persona de Mediana Edad , Inhibidores de la Síntesis de la Proteína/efectos adversos , Inhibidores de la Síntesis de la Proteína/uso terapéutico , Infección de Heridas/tratamiento farmacológico , Infección de Heridas/etiologíaRESUMEN
The focus of this paper is on the development of a wearable electronic network that provides data and power transport. A materials and manufacturing survey was conducted to determine the best performing and most durable materials to withstand the rigors of textile manufacturing and potential military use. Narrow woven technology was selected as the most appropriate manufacturing method. A working wearable narrow fabric version of the Universal Serial Bus (USB) was successfully developed and fabricated as well as related wearable connectors. Military products developed include a personal area network and body borne antenna.
Asunto(s)
Electrónica/instrumentación , Personal Militar , Ropa de Protección , Textiles , Redes de Comunicación de Computadores/instrumentación , Suministros de Energía Eléctrica , Instalación Eléctrica/métodos , Humanos , Textiles/análisis , Estados UnidosRESUMEN
Heparin is an anticoagulant commonly used to treat and prevent deep venous thrombosis. Heparin-induced thrombocytopenia and possible thrombosis are serious complications associated with its use. This can occasionally complicate treatment of patients undergoing podiatric surgery. Heparin-induced thrombocytopenia is often not immediately recognized and is underreported in podiatric medicine literature. The goal of this case report is to highlight the multiple risk factors associated with the development of heparin-induced thrombocytopenia and to aid with early recognition, understanding of pathogenesis, and treatment options.
Asunto(s)
Anticoagulantes/efectos adversos , Pie/cirugía , Heparina/efectos adversos , Trombocitopenia/inducido químicamente , Trombosis/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Periodo Perioperatorio , Trombocitopenia/complicaciones , Trombocitopenia/diagnósticoRESUMEN
BACKGROUND: Peripheral neuropathy is a serious complication of diabetes and several conditions that may lead to the loss of lower extremity function and even amputations. Since the introduction of statins, their use has increased markedly. Recent reports suggest a role for statins in the development of peripheral neuropathy. The aims of the present study were to assess the association between statin use and peripheral neuropathy, and to determine whether this association varied by diabetes status. METHODS: Data from the lower extremity examination supplement of the 1999-2004 National Health and Nutrition Examination Survey were used. RESULTS: The overall prevalence of statin use was 15% and the prevalence of peripheral neuropathy was 14.9%. The prevalence of peripheral neuropathy was significantly higher among those who used statins compared with those who did not (23.5% vs 13.5%, respectively; P < 0.01). Multivariate logistic regression revealed that statin use (adjusted odds ratio 1.3; 95% confidence interval 1.1-1.6; Wald P = 0.04) was significantly associated with peripheral neuropathy, controlling for diabetes status, age, gender, race, height, weight, blood lead levels, poverty, glycohemoglobin, use of vitamin B12 , alcohol abuse, hypertension, and non-high-density lipoprotein-cholesterol. Diabetes status, age, gender, height, weight, blood lead levels, poverty, and glycohemoglobin were also significantly associated with peripheral neuropathy. We found no effect modification between statin use and diabetes status, race, gender, age, vitamin B12 , blood lead levels, or alcohol abuse. CONCLUSIONS: In the present cross-sectional study, we found a modest association between peripheral neuropathy and statin use. Prospective studies are required to determine the causal direction.
Asunto(s)
Neuropatías Diabéticas/epidemiología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Enfermedades del Sistema Nervioso Periférico/epidemiología , Adulto , Anciano , Estudios Transversales , Neuropatías Diabéticas/inducido químicamente , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Prevalencia , Factores de RiesgoRESUMEN
BACKGROUND: There are no conclusive data to support the contention that diabetic patients have an increased frequency of ankle equinus compared with their nondiabetic counterparts. Additionally, a presumed contributing cause of foot ulceration is ankle joint equinus. Therefore, we sought to determine whether persons with diabetes have a higher prevalence of ankle joint equinus than do nondiabetic persons. METHODS: A prospective pilot survey of 102 outpatients (43 diabetic and 59 nondiabetic) was conducted. Demographic and historical data were obtained. Each patient underwent a standard lower-extremity examination, including the use of a biplane goniometer to measure ankle joint range of motion. RESULTS: Equinus, defined as ankle dorsiflexion measured at 0° or less, was found in 24.5% of the overall population. In the diabetes cohort, 16 of 43 patients (37.2%) were affected compared with 9 of 59 nondiabetic participants (15.3%) (P = .011). There was a threefold risk of equinus in the diabetic population (odds ratio [OR], 3.3; 95% confidence interval [CI], 1.28-8.44; P < .013). The equinus group had a history of ulceration in 52.0% compared with 20.8% of the nonequinus group (P = .003). Equinus, therefore, imparted a fourfold risk of ulceration (OR, 4.13; 95% CI, 1.58-10.77; P < .004). We also found a 2.8 times risk of equinus in patients with peripheral neuropathy (OR, 2.8; 95% CI, 1.11-7.09; P < .029). CONCLUSIONS: Equinus may be more prevalent in diabetic patients than previously reported. Although we cannot prove causality, we found a significant association between equinus and ulceration.
Asunto(s)
Diabetes Mellitus/epidemiología , Pie Equino/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Estudios Transversales , Pie Diabético/epidemiología , Neuropatías Diabéticas/epidemiología , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios ProspectivosRESUMEN
We applied Bayesian methods to estimate excess mortality rates by selected causes of death for decedents with diabetes compared to those without diabetes in North Dakota and assessed changes in the excess rate between 1992-1998 and 1999-2003. We report the probability (Pr) of a rate decrease in the age-adjusted excess rate and considered the evidence strong if the probability was 0.90 or higher. Among men with diabetes, the evidence was strong for a probable decrease in excess rate for heart disease (8.7 per 1000 to 6.5), cerebrovascular disease (1.2 per 1000 to 0.75) and arterial disease (0.24 per 1000 to 0.08). Among women with diabetes, the evidence was strong for a probable decrease in excess rates for the overall (total) rate (17.8 per 1000 to 12.6), for heart disease (6.1 per 1000 to 4.4), IHD (4.4 per 1000 to 3.1), cerebrovascular disease (1.4 per 1000 to 0.5), arterial disease (0.17 per 1000 to 0.10) and cancer (2.1 per 1000 to 1.3) as underlying cause of death. The data reflect a high likelihood that cause-specific excess mortality is decreasing for men, and especially for women, with diabetes.
Asunto(s)
Arteriopatías Oclusivas/mortalidad , Causas de Muerte , Diabetes Mellitus/mortalidad , Cardiopatías/mortalidad , Neoplasias/mortalidad , Accidente Cerebrovascular/mortalidad , Teorema de Bayes , Femenino , Humanos , Masculino , Isquemia Miocárdica/mortalidad , North Dakota/epidemiología , Enfermedades Respiratorias/mortalidad , Caracteres SexualesRESUMEN
OBJECTIVE: To examine the association between physicians' reimbursement perceptions and outpatient test performance among patients with diabetes mellitus. STUDY DESIGN: Cross-sectional analysis. METHODS: Participants were physicians (n = 766) and their managed care patients with diabetes mellitus (n = 2758) enrolled in 6 plans in 2003. Procedures measured included electrocardiography, radiography or x-ray films, urine microalbumin levels, glycosylated hemoglobin levels, and Pap smears for women. Hierarchical logistic regression models were adjusted for health plan and physician-level clustering and for physician and patient covariates. To minimize confounding by unmeasured health plan variables, we adjusted for health plan as a fixed effect. Therefore, we estimated variation between physicians using only the variance within health plans. RESULTS: Patients of physicians who reported reimbursement for electrocardiography were more likely to undergo electrocardiography than patients of physicians who did not perceive reimbursement (unadjusted mean difference, 4.9%; 95% confidence interval, 1.1%-8.9%; and adjusted mean difference, 3.9%; 95% confidence interval, 0.2%-7.8%). For the other tests examined, no significant differences in procedure performance were found between patients of physicians who perceived reimbursement and patients of physicians who did not perceive reimbursement. CONCLUSIONS: Reimbursement perception was associated with electrocardiography but not with other commonly performed outpatient procedures. Future research should investigate how associations change with perceived amount of reimbursement and their interactions with other influences on test-ordering behavior such as perceived appropriateness.
Asunto(s)
Actitud del Personal de Salud , Pruebas Diagnósticas de Rutina/estadística & datos numéricos , Médicos/psicología , Pautas de la Práctica en Medicina/economía , Adulto , Atención Ambulatoria/economía , Atención Ambulatoria/métodos , Estudios Transversales , Diabetes Mellitus/fisiopatología , Pruebas Diagnósticas de Rutina/economía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reembolso de IncentivoRESUMEN
OBJECTIVE: To estimate the 2009 prevalence of diagnosed diabetes in Puerto Rico among adults > 20 years of age in order to gain a better understanding of its geographic distribution so that policymakers can more efficiently target prevention and control programs. METHODS: A Bayesian multilevel model was fitted to the combined 2008-2010 Behavioral Risk Factor Surveillance System and 2009 United States Census data to estimate diabetes prevalence for each of the 78 municipios (counties) in Puerto Rico. RESULTS: The mean unadjusted estimate for all counties was 14.3% (range by county, 9.9%-18.0%). The average width of the confidence intervals was 6.2%. Adjusted and unadjusted estimates differed little. CONCLUSIONS: These 78 county estimates are higher on average and showed less variability (i.e., had a smaller range) than the previously published estimates of the 2008 diabetes prevalence for all United States counties (mean, 9.9%; range, 3.0%-18.2%).
OBJETIVO: Calcular la prevalencia en el año 2009 de casos con diagnóstico de diabetes en Puerto Rico en adultos de 20 años de edad o mayores, para conocer mejor su distribución geográfica con objeto de que los responsables políticos puedan encauzar más eficientemente los programas de prevención y control. MÉTODOS: Se ajustó un modelo multinivel bayesiano a la combinación de datos del Sistema de Vigilancia de Factores de Riesgo del Comportamiento 2008-2010 y del Censo de los Estados Unidos del 2009 para calcular la prevalencia de la diabetes en cada uno de los 78 municipios de Puerto Rico. RESULTADOS: El cálculo del valor medio no ajustado para todos los municipios fue de 14,3% (intervalo por municipio de 9,9 a 18,0%). La amplitud promedio de los intervalos de confianza fue de 6,2%. Hubo poca diferencia entre los cálculos ajustados y los no ajustados. CONCLUSIONES: Los valores obtenidos mediante estos cálculos correspondientes a 78 municipios fueron por término medio más elevados y mostraron menor variabilidad (es decir, el intervalo era más pequeño) que los cálculos anteriormente publicados sobre la prevalencia de la diabetes en todos los municipios de los Estados Unidos en el 2008 (media, 9,9%; intervalo de 3,0 a 18,2%).